Investigational Site Number 616001

Warsaw 04-730

0 studies enrolling now · 9 studies all time

What they study most

Acute Coronary Syndrome, Arrhythmia Prophylaxis, Diffuse Large B-cell Lymphoma, Fabry Disease, Ovarian Cancer Recurrent, Small Cell Lung Cancer, Type 2 Diabetes, Ventricular Arrhythmia

Studies at this site

• Evaluation of the Long-term Safety, Pharmacodynamics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-Naïve Adult Male Patients With Fabry Disease — Completed
• A Study of Renal Function in Treatment-naïve, Young Male Patients With Fabry Disease — Stopped early
• Evaluate the Safety, Pharmacodynamics, Pharmacokinetics, and Exploratory Efficacy of GZ/SAR402671 in Treatment-naïve Adult Male Patients With Fabry Disease — Completed
• SAR3419 as Single Agent in Relapsed-Refractory Diffuse Large B-Cell Lymphoma (DLBCL) Patients — Completed
• Efficacy and Safety of Insulin Glargine/ Lixisenatide Fixed Ratio Combination Compared to Insulin Glargine Alone and Lixisenatide Alone on Top of Metformin in Patients With T2DM — Completed
• Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death — Completed
• Effect of Otamixaban Versus Unfractionated Heparin + Eptifibatide in Patients With Unstable Angina/Non ST Elevation Myocardial Infarction Undergoing Early Invasive Strategy — Completed
• Study of Ombrabulin in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Treated With Carboplatin/Paclitaxel — Completed
• Cabazitaxel Compared to Topotecan for the Treatment of Small Cell Lung Cancer — Completed